Gestational Diabetes Increases Heart Disease Risk in Babies

CAITLIN WILLIAMS | July 22, 2018

article image
Gestational diabetes occurs in pregnant women who have high blood glucose (sugar) levels and have not previously had diabetes, usually around the 24th week. A 2014 study from the Center for Disease Control stated that gestational diabetes prevalence is as high as 9.2%. Gestational diabetes can affect both mothers and unborn children, a recent study has shown that gestational diabetes may increase the risk of heart disease in offspring.

Spotlight

Vanton Research Laboratory, LLC

Vanton Resesarch Laboratory. LLC is a rapid growing pharmaceutical CRO and a specialty pharma company with California HHS granted GMP facility and DEA granted controlled substance license, we specialize in developing novel platform technologies and niche drug delivery systems for various dosage forms – oral controlled release and sustained release tablets, rapid disintegration tablets, transdermal patches, injectable solutions, suspensions, emulsions, microparticles, and liposome formulations.

OTHER ARTICLES

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 6, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | March 6, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | March 6, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Roche Prepares to Launch COVID-19 Antibody Test System

Article | March 6, 2020

Swiss pharma giant Roche is joining the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease. This morning, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to detect antibodies in people who have been exposed to the SARS-CoV-2, the virus that causes COVID-19. Roche is eying May for the launch of the test in Europe and is in talks with the U.S Food and Drug Administration for emergency approval of the system. Antibody testing is central to help identify people who have been infected by the virus, especially those who may have been infected but did not display symptoms, the company said. Roche noted that as more information becomes available about immunity levels to COVID-19, society can return to a sense of normal much more quickly. Roche’s test will join a number of other antibody tests that have recently come on the market. Earlier this month the U.S. Food and Drug Administration approved the first blood test for COVID-19 antibodies.

Read More

Spotlight

Vanton Research Laboratory, LLC

Vanton Resesarch Laboratory. LLC is a rapid growing pharmaceutical CRO and a specialty pharma company with California HHS granted GMP facility and DEA granted controlled substance license, we specialize in developing novel platform technologies and niche drug delivery systems for various dosage forms – oral controlled release and sustained release tablets, rapid disintegration tablets, transdermal patches, injectable solutions, suspensions, emulsions, microparticles, and liposome formulations.

Events